Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Hologenix, LLC, the manufacturer of Celliant® technology, appoints Jim Calhoun CEO

Hologenix,LLC
Posted on: 05 Dec 17
Hologenix, LLC, the manufacturer of Celliant® technology, appoints Jim Calhoun CEO

PR Newswire

SANTA MONICA, Calif., Dec. 5, 2017

SANTA MONICA, Calif., Dec. 5, 2017 /PRNewswire/ -- Hologenix, LLC today announced the appointment of Jim Calhoun as chief executive officer. He replaces co-founder, Seth Casden in the CEO position, enabling Casden to focus on sales, science and innovation. Calhoun remains an officer on the Hologenix board of directors and was most recently president and CEO of Converse, a wholly-owned subsidiary of NIKE, Inc.

Celliant is a patented responsive textile technology that harnesses and recycles the body's natural energy through the use of fiber. In July, Celliant received a much-coveted classification from the U.S. Food and Drug Administration (FDA) as a medical device and general wellness product. Celliant is used in more than 60 countries and across a variety of industries, including bedding, apparel, furniture and pet products.

"Jim has spent 25 years working at some of the most successful and iconic global brands in the consumer products industry," said Bill Werlin, chairman of the board. "I speak for the entire board when I say we are thrilled to have him as CEO."

Calhoun led the resurgence of the Converse brand and business worldwide. Prior to that, he served as CEO of Hurley International LLC, an affiliate of Nike Inc, president of the Dockers Brand and executive VP at Levi Strauss & Co. in San Francisco.

"After working in footwear, apparel and retail for 25+ years, I recognize this rare opportunity to be groundbreaking and disruptive in this space. I'm looking forward to introducing Celliant to the massive opportunities in wellness, self-care and performance apparel. We are changing the way that people think about textiles," said Calhoun.

About Hologenix, LLC and Celliant®

Hologenix, LLC, Celliant's (www.celliant.com) parent company, is committed to developing and marketing products that improve people's lives. Celliant is a patented clinically-tested textile technology that harnesses and recycles the body's natural energy through the medium of fibers. The U.S. Food and Drug Administration (FDA) has classified it as a medical device and general wellness product, as defined in Section 201(h) of the Federal Food, Drug and, Cosmetic Act. Celliant's applied science utilizes a blend of minerals and proprietary ingredients embedded into the core of the fiber. Use of products containing this technology has been clinically proven to improve athletic performance, sleep quality and wellness.

 

View original content:http://www.prnewswire.com/news-releases/hologenix-llc-the-manufacturer-of-celliant-technology-appoints-jim-calhoun-ceo-300566882.html

SOURCE Hologenix, LLC

PR Newswire
www.prnewswire.com

Last updated on: 05/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.